THENA Capital podcast with Baroness Susan Greenfield

THENA Capital podcast with Baroness Susan Greenfield

Baroness Susan Greenfield sharing her perspective with Esther Reynal de St Michel Richardot on these important topics: Healthcare-related challenges that policy making is trying to address How it is impacting how innovations can reach patients The importance of having...

read more
Xenopat Meeting – Barcelona 15/02/2024

Xenopat Meeting – Barcelona 15/02/2024

Our CEO Susan Greenfield and Operations Direction Sara Garcia-Rates, joined Xenopat for a face-to-face meeting in Barcelona where they shared the progress made for the Tecniospring Industry project “Development of a T14 Inhibitor for Treatment of ColoRectal Cancer”,...

read more
Susan Greenfield speaking at OBN’s BioTuesday

Susan Greenfield speaking at OBN’s BioTuesday

Susan would like to mention her following thoughts with regards to the OBN presentation: "Our technology is based on the previously unknown neurochemical (T14), that is doubled in the Alzheimer brain. We are developing a pre-symptomatic screen where T14 could be...

read more
NeuroBio logo

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from Neuro-Bio

You have Successfully Subscribed!